{"id":523371,"date":"2021-08-04T16:10:52","date_gmt":"2021-08-04T20:10:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/"},"modified":"2021-08-04T16:10:52","modified_gmt":"2021-08-04T20:10:52","slug":"clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/","title":{"rendered":"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOLANA BEACH, Calif., Aug.  04, 2021  (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its ClearPoint Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris, France.<\/p>\n<p align=\"justify\">\u201cWe have embarked on a promising clinical trial collaboration with ClearPoint Neuro for laser interstitial thermal ablations in pediatric neurosurgical brain pathologies. The use of ClearPoint will allow the entire procedure to take place within the MRI suite, instead of moving the patient from the operating room to the MRI, as is the workflow with current commercially available systems,\u201d stated Dr. Georg Dorfm\u00fcller, Chief of Pediatric Neurosurgery at H\u00f4pital Fondation Rothschild. \u201cIntra-procedural MRI guidance can allow a neurosurgeon to modify a planned laser probe trajectory prior to insertion, or correct probe placement if it appears suboptimal on imaging. For larger, more complex intracerebral lesions, we believe using ClearPoint will also help with the placement of more than one laser probe. The ClearPoint team has been supportive, and we are eager to begin the planned clinical trial in the very near future.\u201d<\/p>\n<p align=\"justify\">\u201cH\u00f4pital Fondation Rothschild has a long history of adopting cutting edge technologies for head and neck indications,\u201d commented Matt Rabon, Clinical and Business Development Manager, EMEA. \u201cNow that we have a European-based team in place, we look forward to supporting Dr. Dorfm\u00fcller, and advancing our strategy to set up additional trial centers in the EU, UK and Middle East to support both our biologics and device partnerships. Each of these installations provides us with an opportunity to treat patients today with meaningful device therapies, and to empower brilliant researchers to conduct clinical trials in both the biologics and device spaces using ClearPoint technology. Expanding and supporting the EU installation base also represents ClearPoint Neuro\u2019s strategic investment in the region by enabling future partnerships with pharmaceutical and biotech companies to discover therapies for the most complex neurological disorders.\u201d<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About ClearPoint Neuro<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">ClearPoint Neuro\u2019s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Company\u2019s current product portfolio include deep brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint\u00ae Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active sites in the United States, Canada, and Europe. ClearPoint Neuro is partnered with over 30 biologics\/pharmaceutical companies and academic centers, providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide. To date, more than 4,500 cases have been performed and supported by the Company\u2019s field-based clinical specialist team. For more information, please visit www.clearpointneuro.com.<\/p>\n<p>\n        <strong><br \/>\n          <u>Forward-Looking Statements<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Statements herein concerning the Company\u2019s plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company&#8217;s future events, developments and future performance, as well as management&#8217;s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company&#8217;s actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: the impact of COVID-19 and the measures adopted to contain its spread; future revenues from sales of the Company\u2019s ClearPoint Neuro Navigation System products; and the Company\u2019s ability to market, commercialize and achieve broader market acceptance for the Company\u2019s ClearPoint Neuro Navigation System products. More detailed information on these and additional factors that could affect the Company\u2019s actual results are described in the \u201cRisk Factors\u201d section in the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2020, and the Company\u2019s Quarterly Report on Form 10-Q for the three months ended March 31, 2021, both of which have been filed with the Securities and Exchange Commission, and the Company\u2019s Quarterly Report on Form 10-Q for the three months ended June 30, 2021, which the Company intends to file with the Securities and Exchange Commission on or before August 16, 2021.<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/fcc6f073-d13f-4ac3-9848-7255070ef3df\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contact:\r\n\r\nJacqueline Keller, Vice President, Marketing\r\n1 (888) 287-9109\r\ninfo@clearpointneuro.com\r\n\r\nCaroline Corner, Investor Relations\r\nir@clearpointneuro.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOLANA BEACH, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its ClearPoint Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris, France. \u201cWe have embarked on a promising clinical trial collaboration with ClearPoint Neuro for laser interstitial thermal ablations in pediatric neurosurgical brain pathologies. The use of ClearPoint will allow the entire procedure to take place within the MRI suite, instead of moving the patient from the operating room to the MRI, as is the workflow with current commercially available systems,\u201d stated Dr. Georg Dorfm\u00fcller, Chief of Pediatric Neurosurgery at H\u00f4pital Fondation Rothschild. \u201cIntra-procedural MRI guidance can allow a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-523371","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOLANA BEACH, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its ClearPoint Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris, France. \u201cWe have embarked on a promising clinical trial collaboration with ClearPoint Neuro for laser interstitial thermal ablations in pediatric neurosurgical brain pathologies. The use of ClearPoint will allow the entire procedure to take place within the MRI suite, instead of moving the patient from the operating room to the MRI, as is the workflow with current commercially available systems,\u201d stated Dr. Georg Dorfm\u00fcller, Chief of Pediatric Neurosurgery at H\u00f4pital Fondation Rothschild. \u201cIntra-procedural MRI guidance can allow a &hellip; Continue reading &quot;ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-04T20:10:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris\",\"datePublished\":\"2021-08-04T20:10:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/\"},\"wordCount\":706,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/\",\"name\":\"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=\",\"datePublished\":\"2021-08-04T20:10:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/","og_locale":"en_US","og_type":"article","og_title":"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris - Market Newsdesk","og_description":"SOLANA BEACH, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its ClearPoint Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris, France. \u201cWe have embarked on a promising clinical trial collaboration with ClearPoint Neuro for laser interstitial thermal ablations in pediatric neurosurgical brain pathologies. The use of ClearPoint will allow the entire procedure to take place within the MRI suite, instead of moving the patient from the operating room to the MRI, as is the workflow with current commercially available systems,\u201d stated Dr. Georg Dorfm\u00fcller, Chief of Pediatric Neurosurgery at H\u00f4pital Fondation Rothschild. \u201cIntra-procedural MRI guidance can allow a &hellip; Continue reading \"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-04T20:10:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris","datePublished":"2021-08-04T20:10:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/"},"wordCount":706,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/","name":"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=","datePublished":"2021-08-04T20:10:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMzAwNyM0MzQyMTE1IzIwMjcxMjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-installation-of-clearpoint-neuro-navigation-system-at-hopital-fondation-rothschild-in-paris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ClearPoint Neuro, Inc. Announces Installation of ClearPoint\u00ae Neuro Navigation System at H\u00f4pital Fondation Rothschild in Paris"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/523371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=523371"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/523371\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=523371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=523371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=523371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}